Pages that link to "Q36953325"
Jump to navigation
Jump to search
The following pages link to Recombinant adeno-associated virus transduction and integration (Q36953325):
Displaying 50 items.
- Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies (Q24630417) (← links)
- Adeno-associated virus for cystic fibrosis gene therapy (Q26823156) (← links)
- Recombinant adeno-associated viral (rAAV) vectors mediate efficient gene transduction in cultured neonatal and adult microglia (Q28386583) (← links)
- Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous (Q33622746) (← links)
- Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular Dystrophy (Q33678893) (← links)
- Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice (Q33681127) (← links)
- High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors (Q33713361) (← links)
- Gene therapy in large animal models of human genetic diseases. Introduction (Q33808511) (← links)
- Gene and cell-mediated therapies for muscular dystrophy. (Q33831193) (← links)
- Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria (Q33832790) (← links)
- Mesenchymal Stem Cells Overexpressing Interleukin-10 Promote Neuroprotection in Experimental Acute Ischemic Stroke (Q33887223) (← links)
- Gene therapy: design and prospects for craniofacial regeneration (Q34007347) (← links)
- Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6. (Q34473295) (← links)
- Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors (Q34566454) (← links)
- Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells (Q34886209) (← links)
- Therapeutic approaches to muscular dystrophy. (Q34982869) (← links)
- Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency (Q35006603) (← links)
- Rapid Transport of Muco-Inert Nanoparticles in Cystic Fibrosis Sputum Treated with N -Acetyl Cysteine (Q35007154) (← links)
- Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain (Q35044451) (← links)
- Systemic RNAi delivery to the muscles of ROSA26 mice reduces lacZ expression (Q35225707) (← links)
- Gene therapy for neurologic manifestations of mucopolysaccharidoses (Q35362251) (← links)
- Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector (Q35513407) (← links)
- Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques (Q35568499) (← links)
- MicroRNA delivery for regenerative medicine (Q35863950) (← links)
- Replication of an Autonomous Human Parvovirus in Non-dividing Human Airway Epithelium Is Facilitated through the DNA Damage and Repair Pathways (Q35893761) (← links)
- Integration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver (Q36014088) (← links)
- Host Anti-antibody Responses Following Adeno-associated Virus-mediated Delivery of Antibodies Against HIV and SIV in Rhesus Monkeys (Q36582838) (← links)
- Gene targeting in ischemic heart disease and failure: translational and clinical studies (Q36617570) (← links)
- Oral vaccination with adeno-associated virus vectors expressing the Neu oncogene inhibits the growth of murine breast cancer. (Q36659250) (← links)
- Extracorporeal delivery of rAAV with metabolic exchange and oxygenation (Q36715322) (← links)
- Enhancing Transgene Expression from Recombinant AAV8 Vectors in Different Tissues Using Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element (Q36792325) (← links)
- Ultrasound targeted microbubble destruction stimulates cellular endocytosis in facilitation of adeno-associated virus delivery (Q36913644) (← links)
- Emerging strategies for cell and gene therapy of the muscular dystrophies (Q36960845) (← links)
- Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo (Q37066326) (← links)
- Antioxidant enzyme gene transfer for ischemic diseases (Q37398189) (← links)
- Human studies of angiogenic gene therapy (Q37406656) (← links)
- Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle (Q37419632) (← links)
- Sarcoplasmic reticulum Ca(2 ) ATPase as a therapeutic target for heart failure (Q37676218) (← links)
- Gene therapy for mesothelioma and lung cancer (Q37693512) (← links)
- Heparin-binding correlates with increased efficiency of AAV1- and AAV6-mediated transduction of striated muscle, but negatively impacts CNS transduction (Q37731803) (← links)
- Preclinical studies for gene therapy of Duchenne muscular dystrophy. (Q37760380) (← links)
- Leptin gene therapy in the fight against diabetes (Q37778403) (← links)
- Gene Therapy for Mesothelioma (Q37868973) (← links)
- Status of therapeutic gene transfer to treat cardiovascular disease in dogs and cats (Q37884788) (← links)
- miRNA cassettes in viral vectors: Problems and solutions (Q37890571) (← links)
- Adeno-Associated Virus Biology (Q37950280) (← links)
- Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function (Q38025012) (← links)
- New developments in the use of gene therapy to treat Duchenne muscular dystrophy (Q38168863) (← links)
- Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes. (Q38321965) (← links)
- Vaccines: A review of immune-based interventions to prevent and treat disease (Q38364468) (← links)